Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-06-29 to 2022-07-11
Current total value of award: $2253.2
Description: 8509203223!TYPHOID VI POLYSACC